Tim Lu’s quest to break new cell therapy ground with gene circuits gets Bayer’s backing in a big new financing round

When Tim Lu spun himself out of MIT to devote some serious attention to his biotech startup Senti Biosciences more than 3 years ago, it …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Tim Lu’s quest to break new cell ther­a­py ground with gene cir­cuits gets Bay­er’s back­ing in a big new fi­nanc­ing round